Mesenchymal Stem Cell Preparation via Trophoblast Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing mesenchymal stem cells face challenges such as long cycle times, low yield, and contamination by xeno pathogens, which hinder their commercialization as therapeutic agents.
Innovation Solution
A method involving culturing expanded potential stem cells in a trophoblast stem cell differentiation medium followed by a mesenchymal stem cell differentiation medium, and then passaging in an MSC expansion medium, using serum-free and xeno-source-free culture systems to maintain cell characteristics and prevent contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If human pluripotent stem cells are induced to differentiate into mesenchymal stem cells using conventional methods, then mesenchymal stem cells can be obtained, but the preparation cycle is long and the yield is low
Solution Approach 1:
The differentiation process is divided into multiple sequential stages: first inducing trophoblast stem cells from pluripotent stem cells, then differentiating these into mesenchymal stem cells. This segmented approach optimizes each stage independently, reducing overall preparation time and increasing yield compared to direct differentiation methods.
Solution Approach 2:
The method performs preliminary expansion of pluripotent stem cells before differentiation, and uses specific pre-differentiation cultures (trophoblast stem cell stage) to prepare the cells in advance. This preliminary action ensures a sufficient cell population is ready for efficient mesenchymal differentiation, thereby increasing final yield and reducing total cycle time.
2Productivity
If conventional differentiation methods are used to prepare mesenchymal stem cells, then cell production is achieved, but contamination by xeno pathogens occurs
Solution Approach 1:
The method extracts and eliminates xenogeneic components from the culture system by using only human-derived reagents and components. The differentiation medium and expansion medium are formulated without any animal-derived products, thereby taking out the source of xeno pathogen contamination while maintaining cell production capacity.
Solution Approach 2:
The method changes the chemical composition parameters of the culture media by replacing serum-containing formulations with serum-free formulations, and replacing animal-derived components with human-derived alternatives. This parameter change in medium composition eliminates contamination risks while supporting robust cell production.
3Quantity of substance
If mesenchymal stem cells are passaged multiple times to increase yield, then cell quantity increases, but cell characteristics may deteriorate
Solution Approach 1:
The expansion medium is formulated with specific human-derived components including human platelet lysate and human albumin that actively support and maintain mesenchymal stem cell characteristics during passaging. This self-service approach through optimized medium composition enables cells to maintain their identity while increasing in quantity over multiple passages.
Solution Approach 2:
The method changes the medium composition parameters by incorporating specific growth factors, cytokines, and human-derived proteins that create an optimal environment for maintaining cell characteristics. These parameter changes in the expansion medium ensure cells retain their multipotent differentiation capacity and surface marker expression even after extensive passaging.
Data Source
AI summary
A method for preparing mesenchymal stem cells (MSCs) is provided. The method includes providing expanded potential stem cells or a first cell culture including the expanded potential stem cells; culturing the expanded potential stem cells or the first cell culture in a trophoblast stem cell (TSC) differentiation medium to obtain trophoblast stem cells or a second cell culture including the trophoblast stem cells; culturing the trophoblast stem cells or the second cell culture in a mesenchymal stem cell (MSC) differentiation medium to obtain mesenchymal stem cells or a third cell culture including the mesenchymal stem cells; and passaging the mesenchymal stem cells or the third cell culture in an MSC expansion medium while maintaining characteristics of the mesenchymal stem cells.